CVAC “CureVac’s vaccines — which have never made it to approval but have some trial data backing them — can be made in 1 microgram doses, they can be made much faster than, say, Moderna’s vaccines. Hoerr says they could build millions of doses by summer, when they hope to start trials, and over a billion in a year or year and half.”
Market Data 
Markets 
AI
